Kentucky still leads the nation in new lung cancer cases, clocking in at 83.9 per 100,000 residents against a national average of 52.1, according to the American Lung Association’s ninth annual “State of Lung Cancer” report released Tuesday.
The commonwealth ranks last among the 50 states and Washington, D.C., Kentucky Lantern reported, though the incidence rate has ticked down 7% over the past five years. Lung cancer remains the leading cause of cancer deaths both in Kentucky and across the country, with the association estimating more than 229,000 new diagnoses nationwide this year.
“Overall, our report reveals positive news—more people in the U.S. and in Kentucky are living longer after a lung cancer diagnosis than ever before, and more people are getting screened for the disease,” said Shannon Baker, director of advocacy for the American Lung Association. “While these findings give us hope, more still must be done to end the burden of this devastating disease on families throughout Kentucky.”
Smoking — the leading risk factor — dropped from 17.4% of adults last year to 15.2% this year, moving Kentucky from second-highest to third-highest nationally, the association’s press release noted. Radon, the second leading cause, also looms large: 36.9% of test results in the state meet or exceed the EPA’s recommended action level, placing Kentucky 38th out of 51.

Survival gains are real but fragile. Kentucky’s five-year survival rate hit 26.3%, a 29% relative improvement over five years, yet the state sits 38th out of 43 with data, well below the 31% national mark. Early diagnosis climbed 19% to 28.4% of cases, roughly even with the 29.3% national rate and landing Kentucky 32nd out of 47.
Screening tells a brighter story. At 25.9% of eligible high-risk adults, Kentucky bests the 24.4% national average and ranks 18th out of 50, WKYT reported. The U.S. Preventive Services Task Force recommends annual low-dose CT scans for adults 50 to 80 with at least a 20-pack-year history who currently smoke or quit within the past 15 years.
“We need to continue to increase screening rates among those at high risk to catch the disease early when it’s more likely to be curable and improve access to clinical trials and the best lung cancer care,” Baker said.
Disparities persist beneath the averages. In Kentucky, 24.6% of lung cancer cases among Black residents were caught early, compared with 28.7% among white residents, while Asian or Pacific Islander patients were the least likely to receive an early diagnosis, the association found.
Treatment metrics sit in the middle of the pack. Surgery as a first course of treatment reached 19.9% of cases — 22nd out of 40 nationally — while 21% of patients received no treatment at all, ranking 29th out of 47. The association warned that no one should go untreated because of provider gaps, stigma, fatalism, or cost.
The report also tracks insurance coverage for comprehensive biomarker testing, a lever for personalized therapy that Kentucky lawmakers have recently moved to require.